Cutting-edge biomaterial in implantable devices: From biocompatibility to biointegration

Significant developments in biomaterials have accelerated the development of implantable medical devices by facilitating the transition from passive structures to responsive, multifunctional platforms. The most recent developments in implantable biomaterials are thoroughly reviewed in this study, with special attention paid to the mechanical compatibility, biocompatibility, degradation behaviours, and biointegration with host tissues of the materials. The structural and biological performance of materials such as β-type titanium alloys, biodegradable metals based on magnesium, ceramics such as zirconia and hydroxyapatite (HA), and polymers such as PCL and PLGA have been investigated. The design of anatomically accurate, patient-specific implants that can dynamically adapt to the physiological environment has been made possible by the combination of additive manufacturing (3D/4D) printing, smart coatings, and stimuli-responsive polymers. Surface characteristics, such as chemistry, topography, and wettability, are crucial in regulating cellular behaviour, immunological response, and protein adsorption. Emerging strategies, such as drug-eluting implants, immunomodulatory coatings, and bioinspired hybrid materials, offer promising avenues for reducing inflammation, promoting healing, and ensuring long-term function. The clinical applications covered include orthopedic, dental, cardiovascular, and neuroprosthetic implants. This review focuses on the manufacturing, sterilization, and regulatory challenges that are critical for clinical translation. The combination of materials science, tissue engineering, and bioelectronics enables the development of next-generation implants that improve functionality, patient outcomes, and digital health integration. Such convergence necessitates a multidisciplinary approach to develop implants that are both structurally strong and biologically intelligent.